Madison Square Garden Sports

MSGSNYSEUSD

THESIS ALERT

Email me when the MSGS thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$384.39
+$91.75 (+31.35%)Today 1M +4.47%

Updated Oct 26, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$388.63
Prior regular-session close from the quote source.
$383.11–$392.56
Regular-session low and high so far today.
261.3K
Regular-session shares traded · Oct 26, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$158.81–$392.56
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own MSGS if that scarcity translates into cash flow or value realization despite thin GAAP margins and leverage.

MSGS price history

Latest price$384.39Today+$91.75 (+31.35%)
MSGS -6.33%S&P 500 -1.69%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Scarcity of New York professional sports assets and live-fan demand keep giving MSGS monetization power across tickets, premium experiences, sponsorship, and media-related economics, so demand continues to convert into revenue.StrengtheningMateriality: High

    GAAP annual revenue rose from $821.4 million in FY2022 to $1.1538 billion in FY2026. If this holds, the company has a durable top-line engine; if it breaks, the trophy-asset valuation rests on weakening commercial demand.

    Watch: New York fans or corporate buyers resist further ticket, suite, or sponsorship price increases after weak team performance or consumer pressure.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual revenue rose from $821.4 million in FY2022 to $1.1538 billion in FY2026.

    Open source ↗
  • The company’s sports-asset pricing power must outrun player payroll, league costs, venue expenses, and other operating inflation; otherwise incremental revenue will not become owner earnings.HoldingMateriality: High

    GAAP annual operating income remained positive at $28.9 million in FY2026. This determines whether MSGS is an earnings and cash-flow compounding business or merely a valuable asset with poor public-company profitability.

    Watch: NBA or NHL salary-cap, luxury-tax, revenue-sharing, or player-compensation rules shift more economics from owners to labor.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating income remained positive at $28.9 million in FY2026.

    Open source ↗
  • Advance sales, sponsorship collections, league/media distributions, and live-event economics need to produce recurring operating cash flow sufficient to support the capital structure without relying on equity dilution or asset sales.HoldingMateriality: Medium

    GAAP annual operating cash flow was positive at $62.7 million in FY2026. Cash generation is what lets shareholders wait for franchise-value realization; if it weakens, leverage and liquidity become the story.

    Watch: Season-ticket or sponsorship cash collections weaken before revenue recognition, signaling lower forward demand.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating cash flow was positive at $62.7 million in FY2026.

    Open source ↗
  • MSGS’s balance sheet remains investable only if lenders and markets continue to underwrite the private-market value and cash-flow durability of its sports assets despite negative book equity.WeakeningMateriality: Medium

    Cash increased from $144.6 million at FY2025 year-end to $164.5 million at FY2026 year-end. If financing access remains open, leverage can amplify equity value; if credit support weakens, shareholders face refinancing and control-risk pressure.

    Watch: Credit markets reprice sports-franchise debt or demand tighter covenants because of higher rates or weaker media economics.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Cash increased from $144.6 million at FY2025 year-end to $164.5 million at FY2026 year-end.

    Open source ↗
  • Because GAAP earnings are thin and volatile relative to the asset story, public shareholders need disciplined capital allocation or a credible route to franchise-value realization rather than value leakage through control, costs, or financing.HoldingMateriality: Medium

    GAAP diluted EPS moved from a loss of $0.93 in FY2025 to positive $0.32 in FY2026. The asset may be valuable, but the stock only compounds if that value accrues to minority shareholders.

    Watch: Controlling-shareholder or related-party decisions prioritize strategic control, affiliated transactions, or empire-building over minority shareholder returns.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP diluted EPS moved from a loss of $0.93 in FY2025 to positive $0.32 in FY2026.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Scarcity of New York professional sports assets and live-fan demand keep giving MSGS monetization power across tickets, premium experiences, sponsorship, and media-related economics, so demand continues to convert into revenue. If this holds, the company has a durable top-line engine; if it breaks, the trophy-asset valuation rests on weakening commercial demand.

The company’s sports-asset pricing power must outrun player payroll, league costs, venue expenses, and other operating inflation; otherwise incremental revenue will not become owner earnings. This determines whether MSGS is an earnings and cash-flow compounding business or merely a valuable asset with poor public-company profitability.

Advance sales, sponsorship collections, league/media distributions, and live-event economics need to produce recurring operating cash flow sufficient to support the capital structure without relying on equity dilution or asset sales. Cash generation is what lets shareholders wait for franchise-value realization; if it weakens, leverage and liquidity become the story.

MSGS’s balance sheet remains investable only if lenders and markets continue to underwrite the private-market value and cash-flow durability of its sports assets despite negative book equity. If financing access remains open, leverage can amplify equity value; if credit support weakens, shareholders face refinancing and control-risk pressure.

Because GAAP earnings are thin and volatile relative to the asset story, public shareholders need disciplined capital allocation or a credible route to franchise-value realization rather than value leakage through control, costs, or financing. The asset may be valuable, but the stock only compounds if that value accrues to minority shareholders.

All standing thesis claims
Original report summary

that scarcity translates into cash flow or value realization despite thin GAAP margins and leverage.

Evidence assessed Oct 19, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Madison Square Garden Sports

Where the evidence on Madison Square Garden Sports disagrees: Mixed on the latest evidence (Oct 19, 2026). Of its 5 thesis points, 1 strengthening, 3 holding and 1 weakening.

Bull case: what the evidence supports

  • Scarcity of New York professional sports assets and live-fan demand keep giving MSGS monetization power across tickets, premium experiences, sponsorship, and media-related economics, so demand continues to convert into revenue.

    sec.gov ↗

  • The company’s sports-asset pricing power must outrun player payroll, league costs, venue expenses, and other operating inflation; otherwise incremental revenue will not become owner earnings.

    sec.gov ↗

  • Advance sales, sponsorship collections, league/media distributions, and live-event economics need to produce recurring operating cash flow sufficient to support the capital structure without relying on equity dilution or asset sales.

    sec.gov ↗

  • Because GAAP earnings are thin and volatile relative to the asset story, public shareholders need disciplined capital allocation or a credible route to franchise-value realization rather than value leakage through control, costs, or financing.

    sec.gov ↗

Bear case: what the evidence questions

  • MSGS’s balance sheet remains investable only if lenders and markets continue to underwrite the private-market value and cash-flow durability of its sports assets despite negative book equity.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Madison Square Garden Sports

Loading the break-condition record for Madison Square Garden Sports.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Entered a material definitive agreement.

    Madison Square Garden Sports filed an SEC 8-K on 2026-09-30: Entered a material definitive agreement. It is a dated development that tests the current thesis.

  2. Mixed
    Director or principal officer change.

    Madison Square Garden Sports filed an SEC 8-K on 2026-09-22: Director or principal officer change. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    Madison Square Garden Sports filed an SEC 8-K on 2026-08-13: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • New York fans or corporate buyers resist further ticket, suite, or sponsorship price increases after weak team performance or consumer pressure.
  • NBA or NHL salary-cap, luxury-tax, revenue-sharing, or player-compensation rules shift more economics from owners to labor.
  • Season-ticket or sponsorship cash collections weaken before revenue recognition, signaling lower forward demand.
  • Credit markets reprice sports-franchise debt or demand tighter covenants because of higher rates or weaker media economics.
  • Controlling-shareholder or related-party decisions prioritize strategic control, affiliated transactions, or empire-building over minority shareholder returns.

MSGS news

Loading headlines…

Financial statements

MSGS income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

MSGS: quick answers

Which well-known investors own MSGS?
1 of the 37 well-known funds tracked here reported MSGS shares in their latest 13F filing. By share of the fund's portfolio: Gates Foundation Trust (Bill Gates), 0.7%. Fund portfolios

MSGS in well-known investors’ portfolios

1 of 37 funds reported MSGS shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Bill GatesGates Foundation Trust0.69%$238MNo changeQ2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.